Latest SPAC Liquidations: Apeiron Capital Investment Corp.
Apeiron Capital Investment Corp. (APNC) Terminates GIO World Health Deal, Intends to Liquidate on August 14
Apeiron Capital Investment Corp. (OTCMKTS:APNC) announced today that it has notified GIO World Health, Ltd. that it has elected to terminate the deal.
Due to its inability to complete an initial business combination within the time period required, the company intends to liquidate and dissolve, effective as of the close of business on August 14.
The company will redeem all of the outstanding shares of common stock at a per-share redemption price equal to the aggregate amount then on deposit in the trust including interest earned on the funds and not previously released to the company to pay its taxes, divided by the number of outstanding public shares.
As of the close of business on August 14, the shares will be deemed canceled and will represent only the right to receive the redemption amount.
At the SPAC of Dawn The final week of October comes in with a busy slate of votes including one extension today and nine more clustered on Thursday and Friday. Both TMT (NASDAQ:TMTC) and Insight (NASDAQ:INAQ) are set to hold completion votes for their combinations with eLong Power and Alpha Modus, respectively. Meanwhile, the SPAC...
Terms Tracker for the Week Ending October 25, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Finally, a little more SPAC action this week with no less than four IPOs priced. That brings October’s tally to seven IPOs with one more...
At the SPAC of Dawn The rebound of the growth companies that made up the SPAC class of 2021 has been one of the bigger stories of second half of 2024, but not all of the de-SPACs are feeling the love equally. Instead, in many new sectors that hit the public markets together as a...
DT Cloud (NASDAQ:DYCQ) has entered into a definitive agreement to combine with Maius Pharmaceutical at an equity value of $250 million. Shanghai-based Maius is a drug developer and researcher focused on small-molecule chemical treatments for different forms of cancer. The combined company is expected to trade on the Nasdaq once the deal is completed in...
Charlton Aria Acquisition Corporation announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHARU”, Thursday, October 24, 2024. The new SPAC plans to focus on industries that complement the management team’s and board of director’s background and network. The sponsor team for...